MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-07-0016315
Elbrit Life Sciences Private Limited - pharma in Erode, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹41.77 Cr
▲ 39% YoY
Net profit · FY 2024
₹1.16 Cr
Net margin 2.8%
EBITDA · FY 2024
₹3.05 Cr
EBITDA margin 7.3%
Authorised capital
₹80 Lakh
Registered with MCA
Paid-up capital
₹75.2 Lakh
Issued & subscribed
Open charges
₹10.28 Cr
Satisfied ₹9.4 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
213
Provident fund records
About Elbrit Life Sciences Private Limited
Data last updated:
Elbrit Life Sciences Private Limited is a private limited company based in Erode, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U74999TZ2014PTC029965. Its GSTIN is 33AADCE5937C1ZY (Tamil Nadu). The company holds 11 GST registrations, of which 8 are active.
The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹75.2 Lakh. It is led by directors including Kailasanathan Senthilkumar Prakash (Managing Director) and Karukkupalayam Murugesan Nivedha (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 22/1 Perundurai Road, Erode, Tamil Nadu, India – 638011.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.77 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Cr (net margin 2.8%) and EBITDA of ₹3.05 Cr (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 26% over five years.
The company has about 213 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Elbrit Life Sciences. As per MCA filings, the company has open charges of ₹10.28 Cr and satisfied charges of ₹9.4 Cr on record. Court records list 17 cases involving the company, including 16 filed by the company and 1 filed against it; 1 case is pending. The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in June 2017. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Supercure Biotech Private Limited with revenue of ₹42.03 Cr.
Elbrit Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-07-0016315). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elbrit.org.
Company Details of Elbrit Life Sciences Private Limited
CIN U74999TZ2014PTC029965
Registration Number 029965
Incorporation Date 18 January 2014
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-07-0016315
CIN History
Elbrit Life Sciences has one previous CIN (Corporate Identification Number): U74999MH2014PTC252228. The current CIN is U74999TZ2014PTC029965, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999TZ2014PTC029965 | Current |
| U74999MH2014PTC252228 | Previous |
Key People
Kailasanathan Senthilkumar Prakash Managing Director Karukkupalayam Murugesan Nivedha Whole-Time Director Senthilkumar Kailasanathan Whole-Time Director Recognitions & Rankings of Elbrit Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address22/1 Perundurai Road, Erode, Tamil Nadu, India – 638011
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Elbrit Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands
Elbrit Life Sciences operates one associated brand: Elbrit Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, manufactures, and distributes innovative medications for various health conditions worldwide. | elbrit.org |
Business Activity
The main business activity of Elbrit Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Elbrit Life Sciences Private Limited
FY 2024 filings availableElbrit Life Sciences Private Limited reported revenue of ₹41.77 Cr (up 39% YoY) for FY 2024.
Revenue · FY 2024
₹41.77 Cr ▲ 39%
Net profit · FY 2024
₹1.16 Cr margin 2.8%
EBITDA · FY 2024
₹3.05 Cr margin 7.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 42%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 63%
5 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 39% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹3.05 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹1.16 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 7.3% | |
| Net Profit Margin | 2.8% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2019-20 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elbrit Life Sciences are in the company report.
: available in the company report
Board of Directors of Elbrit Life Sciences Private Limited
Elbrit Life Sciences has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muruhgesan Marappagounder | Director | 30 Aug 2024 | 2 Years 1 Months | Current |
| Karukkupalayam Murugesan Nivedha | Whole-Time Director | 09 Apr 2021 | 5 Years 6 Months | Current |
| Senthilkumar Kailasanathan Also directs: Etsu Healthcare Private Limited | Whole-Time Director | 18 Jan 2014 | 12 Years 9 Months | Current |
| Kailasanathan Senthilkumar Prakash Also directs: Etsu Healthcare Private Limited, Nex Infracon Private Limited | Managing Director | 18 Jan 2014 | 12 Years 9 Months | Current |
Peer Comparison
Elbrit Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Supercure Biotech Private Limited | ₹42.03 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Delhi, India |
| International Ingredients & Excipients Private Limited | ₹41.96 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Chennai, Tamil Nadu, India |
| Samrudh Pharmacare Private Limited | ₹41.88 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Aap Pharma Technologies India Private Limited | ₹41.83 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| Elbrit Life Sciences Private Limited this company | ₹41.77 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Erode, Tamil Nadu, India |
| Crest Lifesciences Private Limited | ₹41.71 Cr (FY 2025) | •••• | •••• | 397.0% | •••• | Baddi, Himachal Pradesh, India |
| Pregio Pharma Private Limited | ₹41.7 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Chennai, Tamil Nadu, India |
| Strava Healthcare Private Limited | ₹41.58 Cr (FY 2025) | •••• | •••• | 115.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the companies nearest to Elbrit Life Sciences by revenue, above and below it, in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Elbrit Life Sciences Private Limited is audited by S DEEPAK for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S DEEPAK | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Open charges
₹10.28 Cr
Satisfied charges
₹9.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2025 | Hdfc Bank Limited | ₹38.4 Lakh | Open |
| 18 Mar 2025 | Hdfc Bank Limited | ₹16.56 Lakh | Open |
| 22 Nov 2024 | Others | ₹8 Cr | Open |
| 14 May 2024 | Hdfc Bank Limited | ₹38.77 Lakh | Open |
| 08 Mar 2023 | Hdfc Bank Limited | ₹23.18 Lakh | Open |
Total charge records: 12 View all charges
Deals & Funding
Elbrit Life Sciences Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in June 2017.
Total deals
2
Rights issue
1
Funding round
1
Disclosed funding
₹10 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2017 | Rights issue | ₹20 Lakh | Investors: 2 individuals |
| Jan 2014 | Funding round | ₹10 Lakh | Investors: 2 individuals |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
Elbrit Life Sciences Private Limited has 17 court cases on record: 16 filed by Elbrit Life Sciences, 1 filed against it. 1 case is pending and 16 are disposed.
Total cases
17
Filed by the company
16
Filed against the company
1
Pending
1
Disposed
16
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 0 | 0 |
| District courts | 5 | 1 | 1 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed against the company | Pending |
| Madras High Court | Writ petition | Filed by the company against The Assistant Commissioner (St) | Disposed |
| Madras High Court | Interim or miscellaneous application | Filed by the company against The Assistant Commissioner (St) | Disposed |
| District court, Erode, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
| District court, Erode, Tamil Nadu | Criminal case | Filed by the company against an individual | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Elbrit Life Sciences Private Limited has a workforce of 213 employees as of Apr 08, 2024.
Employee count
213
Active EPFO establishments
1
Employee growth
54.35%
: available in the company report
Group Structure
Elbrit Life Sciences has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key Subsidiaries
| Company Name | CIN | Shares Held |
|---|---|---|
| Etsu Healthcare Private Limited | U24299MH2020PTC337963 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity
Elbrit Life Sciences Private Limited has 8 board changes on record since 2014: 4 appointments and 4 cessations. The latest: Muruhgesan Marappagounder ceased to be Additional Director on 29 Sep 2024.
Charges
A charge registered on 25 Sep 2019 via Charge ID 100295013 with The South Indian Bank Limited was fully satisfied on 20 Nov 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 38.40 Lakh with Charge ID 101112221 was registered on 23 Jun 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.56 Lakh with Charge ID 101073441 was registered on 18 Mar 2025.
Charges
A charge with Others amounted to Rs. 800.00 Lakh with Charge ID 101016294 was registered on 22 Nov 2024.
AGM
Elbrit Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Muruhgesan Marappagounder ceased to be Additional Director.
Appointed
Muruhgesan Marappagounder was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 38.77 Lakh with Charge ID 100921904 was registered on 14 May 2024.
Filing
Elbrit Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Coimbatore.
Charges
A charge with The South Indian Bank Limited of Rs. 540.39 Lakh registered on 25 Sep 2019 with Charge ID 100295013 was modified on 26 Dec 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.18 Lakh with Charge ID 100730382 was registered on 08 Mar 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.10 Lakh with Charge ID 100667886 was registered on 21 Nov 2022.
17 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Elbrit Life Sciences has 11 GST registrations: 8 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
11
Active
8
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCE5937C1ZY | Tamil Nadu | Active | 01 Jul 2017 |
| 36AADCE5937C1ZS | Telangana | Active | 29 Feb 2020 |
| 34AADCE5937C1ZW | Puducherry | Active | 29 Sep 2020 |
| 29AADCE5937C2ZM | Karnataka | Active | 28 Dec 2020 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Elbrit Life Sciences is an active private limited company based in Erode, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 2014 (12+ years old) and is registered under CIN U74999TZ2014PTC029965.
Elbrit Life Sciences has 4 current directors:
- Kailasanathan Senthilkumar Prakash - Managing Director
- Karukkupalayam Murugesan Nivedha - Whole-Time Director
- Senthilkumar Kailasanathan - Whole-Time Director
- Muruhgesan Marappagounder - Director
The latest financial statements of Elbrit Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Elbrit Life Sciences is 33AADCE5937C1ZY, registered in Tamil Nadu. The company has 11 GST registrations in all, of which 8 are active and 3 are cancelled or inactive. Other active GSTINs include 36AADCE5937C1ZS (Telangana), 34AADCE5937C1ZW (Puducherry), 29AADCE5937C2ZM (Karnataka).
The CIN (Corporate Identification Number) of Elbrit Life Sciences is U74999TZ2014PTC029965. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elbrit Life Sciences has 17 court cases on record: 16 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Elbrit Life Sciences was incorporated on 18 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Coimbatore.
Elbrit Life Sciences has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in June 2017.
The peers of Elbrit Life Sciences by revenue are Supercure Biotech Private Limited, International Ingredients & Excipients Private Limited, Samrudh Pharmacare Private Limited, Aap Pharma Technologies India Private Limited, Crest Lifesciences Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Muruhgesan Marappagounder ceased to be Additional Director on 29 Sep 2024. Muruhgesan Marappagounder was appointed as Director on 30 Aug 2024. Karukkupalayam Murugesan Nivedha ceased to be Additional Director on 30 Nov 2021. Elbrit Life Sciences has 8 board changes on record in total.
Yes, Elbrit Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-TN-07-0016315).